SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001773427-24-000025
Filing Date
2024-08-07
Accepted
2024-08-07 06:34:23
Documents
51
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q swtx-20240630.htm   iXBRL 10-Q 859123
2 EX-31.1 swtx-20240630xex311.htm EX-31.1 11383
3 EX-31.2 swtx-20240630xex312.htm EX-31.2 11402
4 EX-32.1 swtx-20240630xex321.htm EX-32.1 5564
5 EX-32.2 swtx-20240630xex322.htm EX-32.2 5570
  Complete submission text file 0001773427-24-000025.txt   4220314

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT swtx-20240630.xsd EX-101.SCH 21490
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT swtx-20240630_cal.xml EX-101.CAL 49653
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT swtx-20240630_def.xml EX-101.DEF 102888
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT swtx-20240630_lab.xml EX-101.LAB 420408
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT swtx-20240630_pre.xml EX-101.PRE 265222
54 EXTRACTED XBRL INSTANCE DOCUMENT swtx-20240630_htm.xml XML 473724
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39044 | Film No.: 241181319
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)